Literature DB >> 15474264

European collaborative group on prostate brachytherapy: preliminary report in 1175 patients.

S Langley1, R Laing, A Henderson, S Aaltomaa, V Kataja, J-E Palmgren, F Bladou, N Salem, G Serment, L Nava, A Losa, G Guazzoni, F Guedea, F Aguilo, J F Suarez.   

Abstract

OBJECTIVE: To establish a multi-centre database of a large number of patients treated with brachytherapy across Europe.
METHODS: A total of 1175 patient files were registered in the database and the completeness of the data on these patients resulted in the majority being included in the analysis.
RESULTS: The database of patients treated with brachytherapy across Europe indicates that optimal patient selection for this procedure has been made, both in terms of outcome and side-effects, which will be subject of future analyses. This should enable refinement of the treatment choice and administration as well as provide useful guidance to other centres that want to establish this procedure for their patients. It will also set the ground for prospective studies.
CONCLUSIONS: The established database indicates that brachytherapy as a treatment option for prostate cancer is well established in many centres.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474264     DOI: 10.1016/j.eururo.2004.06.008

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  1 in total

1.  Feasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-/very high-risk prostate cancer.

Authors:  Shingo Ashida; Ichiro Yamasaki; Kenji Tamura; Tsutomu Shimamoto; Keiji Inoue; Shinji Kariya; Kana Kobayashi; Takuji Yamagami; Taro Shuin
Journal:  Mol Clin Oncol       Date:  2016-02-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.